Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Jul 21, 2016 $33.38 $34.13 $32.92 $33.45 304 200
Jul 20, 2016 $32.56 $33.47 $32.24 $33.00 293 000
Jul 19, 2016 $32.49 $32.93 $32.00 $32.36 318 100
Jul 18, 2016 $33.04 $33.04 $32.18 $32.46 276 300
Jul 15, 2016 $33.16 $33.65 $32.85 $33.09 207 500
Jul 14, 2016 $33.46 $34.18 $32.43 $32.81 203 100
Jul 13, 2016 $35.34 $35.57 $32.79 $32.87 240 200
Jul 12, 2016 $34.84 $35.52 $34.48 $35.10 224 100
Jul 11, 2016 $34.93 $35.09 $34.00 $34.35 200 100
Jul 08, 2016 $33.75 $34.78 $33.44 $34.75 358 500
Jul 07, 2016 $34.58 $34.93 $33.32 $33.91 255 900
Jul 06, 2016 $32.58 $34.50 $32.53 $34.48 363 100
Jul 05, 2016 $34.95 $35.30 $32.54 $32.77 426 400
Jul 01, 2016 $33.87 $35.35 $33.45 $35.27 448 600
Jun 30, 2016 $35.08 $35.08 $33.56 $33.98 442 900
Jun 29, 2016 $34.40 $35.22 $33.61 $35.00 298 900
Jun 28, 2016 $32.66 $34.00 $32.30 $33.89 326 300
Jun 27, 2016 $33.15 $33.38 $31.55 $31.84 335 100
Jun 24, 2016 $33.19 $34.42 $32.67 $33.46 806 900
Jun 23, 2016 $33.99 $35.21 $33.50 $35.04 372 000
Jun 22, 2016 $33.80 $35.02 $33.19 $33.56 305 100
Jun 21, 2016 $35.09 $35.09 $33.25 $33.73 307 300
Jun 20, 2016 $34.92 $35.70 $34.19 $34.87 222 500
Jun 17, 2016 $36.42 $36.42 $34.25 $34.38 606 900
Jun 16, 2016 $36.38 $36.53 $35.34 $36.30 254 757
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT